Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05424822
Title A Study of JNJ-80948543, a T Cell Redirecting Antibody, in Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

B-cell lymphoma

nodal marginal zone lymphoma

Waldenstroem's macroglobulinemia

mantle cell lymphoma

diffuse large B-cell lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

splenic marginal zone lymphoma

MALT lymphoma

chronic lymphocytic leukemia

Therapies

JNJ-80948543

Age Groups: adult | senior
Covered Countries USA | FRA


No variant requirements are available.